As of 10:31 AM on the 23rd, Celltrion is trading at 260,000 KRW, down 2.99% from the previous day. This represents an 18.24% decrease compared to September 8. Celltrion is known as a manufacturer of protein and biopharmaceutical products.

Today, foreigners have a net purchase of 50,036 shares of Celltrion, while institutions have a net sale of 10,000 shares, according to preliminary data. Over the past five days, individual investors have net purchased 317,188 shares, while foreigners and institutions have net sold 116,437 shares and 223,016 shares, respectively.


On September 18, Celltrion was a market topic due to the "approval news of Phase 2 and 3 clinical trials for the COVID-19 treatment."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing